Lilly CEO bullish on momentum in 2023

This year is slated to be a big one for Indianapolis-based Eli Lilly and Co. as the pharmaceutical giant plans to release four new medicines to the public, with even more in the pipeline. CEO Dave Ricks said the momentum was created by tailwinds in 2022.... Read More

Lilly contributes $1M towards cold chain delivery of meds

Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says it will contribute more $1 million towards the purchase and installation of medical-grade refrigeration units in 17 impoverished nations. Lilly is partnering with Direct Relief, a global humanitarian aid organization, to improve “last mile” delivery of essential medications in low-income regions of the world.... Read More

‘Genetically elite’ soybeans score Pacers deal

A uniquely Indiana business deal involving NBA basketball, a major ag producer and farmers is putting a new crop in the spotlight at one of the biggest Hoosier venues: Gainbridge Fieldhouse. The partnership between the Indiana Soybean Alliance (ISA) and Pacers Sports & Entertainment Inc. means fried food at all Gainbridge Fieldhouse events will be […]... Read More

Music therapy reaches crescendo in Indy

Music therapy is hitting a high note in central Indiana. Two new efforts—one focused on patients and the other on training tomorrow’s clinicians—are expected to give more Hoosiers access to the healing power of music.... Read More

Purdue startup named to most fundable list

For the third consecutive year, a Purdue University-affiliated company has been named to the Most Fundable Companies list from Pepperdine University’s Graziadio Business School. The business school named biotechnology company OmniVis to the prestigious list.... Read More

BiomEdit inks first research partnership

Fishers-based BiomEdit LLC has formed a long-term research and commercial partnership with European animal nutrition company Nutreco. BiomEdit said the partners aim to develop novel feed additives for livestock using microbiome technology.... Read More

California to sue Lilly, other drug companies over insulin prices

California on Thursday announced it will sue the companies—including Indianapolis-based Eli Lilly and Co. (NYSE: LLY)—that make and promote most of the nation’s insulin, accusing them of scheming to illegally increase the price of the drug and demanding they return millions of dollars to some diabetics who state officials say were overcharged for the medicine they must have to survive.... Read More

Low: Purdue support key to startup’s success

A Hoosier life sciences icon who recently received another major win says the ecosystem at Purdue University is a key factor in the success of his West Lafayette-based startup. Dr. Philip Low credited the university's support in an interview with Kylie Veleta.... Read More

Zimmer Biomet grows sports medicine portfolio

Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) says its latest acquisition strengthens its growing sports medicine portfolio. The orthopedics device maker announced it has reached a definitive agreement to acquire Virginia-based Embody Inc., in a deal that could be worth as much as $270 million.... Read More

Life sciences firm to expand, create 1,500 jobs

Cincinnati-based life sciences company Medpace has announced a major expansion, which could benefit workers in southeast Indiana. The medical contract research organization says it will invest $150 million to expand its Ohio headquarters and add 1,500 jobs over the next six years.... Read More

Cancer Center to be new training ground for translational PhDs

Cancer treatment is increasingly moving toward personalized medicine, also called precision medicine, which recognizes that every tumor is unique and must be attacked in a unique way. The approach is powered by genomics, in which scientists sequence the tumor’s DNA. However, IU Simon Comprehensive Cancer Center Associate Director of Education Dr. Hari Nakshatri says the […]... Read More

Concussion app expands to opioids

Dramatic growth since commercializing its product in 2019 is only the first chapter of Brightlamp’s story, says Chief Executive Officer Kurtis Sluss. The Indianapolis-based startup created a smartphone app called Reflex; initially envisioned as a method to detect a concussion within seconds, Sluss says “the single most exciting thing is seeing how [its use] seems […]... Read More